Adrenocorticotropin Hormone Secreting Carcinoma of the Pancreas: A Case Report.

Journal of Pancreatic Cancer Pub Date : 2019-06-20 eCollection Date: 2019-01-01 DOI:10.1089/pancan.2019.0004
Josh Bleicher, Sarah Lombardo, Stacie Carbine, Dmitri Kapitonov, Maria A Pletneva, Sean J Mulvihill
{"title":"Adrenocorticotropin Hormone Secreting Carcinoma of the Pancreas: A Case Report.","authors":"Josh Bleicher,&nbsp;Sarah Lombardo,&nbsp;Stacie Carbine,&nbsp;Dmitri Kapitonov,&nbsp;Maria A Pletneva,&nbsp;Sean J Mulvihill","doi":"10.1089/pancan.2019.0004","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Adrenocorticotropin hormone (ACTH) secreting pancreatic neuroendocrine neoplasms (pNENs) are rare. The clinical and biological behavior of pNENs is poorly understood. Patients often present at an advanced stage of disease and outcomes remain poor. This report demonstrates a case of ectopic Cushing's syndrome secondary to an ACTH-producing pancreatic neuroendocrine carcinoma (pNEC). <b>Case report:</b> A 54-year-old woman presented with rapidly progressive Cushing's syndrome complicated by hypertension and acute heart failure. This was ultimately found to be secondary to a metastatic ACTH-producing pNEC. She underwent laparoscopic distal pancreatectomy and splenectomy with hepatic metastasectomy as primary treatment. She had rapid correction of her endocrine abnormalities and associated physiological abnormalities. She had progressive hepatic metastases found on imaging at 3 months, but remained free of significant endocrine abnormalities for 9 months after surgery. Her disease did recur and she died of complications associated with her disease at 1 year after her surgery. <b>Conclusion:</b> ACTH-producing pNEN is a very rare disease with a poor prognosis. Robust evidence to guide treatment decisions is limited. This report suggests that aggressive surgical management of primary and metastatic lesions for management of this disease is reasonable, consistent with prior case reports. Control of endocrine abnormalities offers the best opportunity for prolonged survival, and an aggressive surgical approach can achieve this goal. The patient presented had control of endocrine abnormalities after surgery for 9 months before symptomatic disease recurrence.</p>","PeriodicalId":16655,"journal":{"name":"Journal of Pancreatic Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/pancan.2019.0004","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pancreatic Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/pancan.2019.0004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Introduction: Adrenocorticotropin hormone (ACTH) secreting pancreatic neuroendocrine neoplasms (pNENs) are rare. The clinical and biological behavior of pNENs is poorly understood. Patients often present at an advanced stage of disease and outcomes remain poor. This report demonstrates a case of ectopic Cushing's syndrome secondary to an ACTH-producing pancreatic neuroendocrine carcinoma (pNEC). Case report: A 54-year-old woman presented with rapidly progressive Cushing's syndrome complicated by hypertension and acute heart failure. This was ultimately found to be secondary to a metastatic ACTH-producing pNEC. She underwent laparoscopic distal pancreatectomy and splenectomy with hepatic metastasectomy as primary treatment. She had rapid correction of her endocrine abnormalities and associated physiological abnormalities. She had progressive hepatic metastases found on imaging at 3 months, but remained free of significant endocrine abnormalities for 9 months after surgery. Her disease did recur and she died of complications associated with her disease at 1 year after her surgery. Conclusion: ACTH-producing pNEN is a very rare disease with a poor prognosis. Robust evidence to guide treatment decisions is limited. This report suggests that aggressive surgical management of primary and metastatic lesions for management of this disease is reasonable, consistent with prior case reports. Control of endocrine abnormalities offers the best opportunity for prolonged survival, and an aggressive surgical approach can achieve this goal. The patient presented had control of endocrine abnormalities after surgery for 9 months before symptomatic disease recurrence.

Abstract Image

Abstract Image

Abstract Image

促肾上腺皮质激素分泌型胰腺癌1例报告。
简介:促肾上腺皮质激素(ACTH)分泌胰腺神经内分泌肿瘤(pNENs)是罕见的。pNENs的临床和生物学行为尚不清楚。患者往往出现在疾病的晚期,结果仍然很差。本文报告一例异位库欣综合征继发于促acth胰腺神经内分泌癌(pNEC)。病例报告:一名54岁女性,表现为进展迅速的库欣综合征并发高血压和急性心力衰竭。最终发现这是继发于转移性acth产生pNEC。她接受了腹腔镜下远端胰腺切除术和脾切除术并肝转移切除术作为主要治疗。她的内分泌异常和相关的生理异常得到了迅速的纠正。患者3个月时影像学发现进展性肝转移,但术后9个月未见明显内分泌异常。她的疾病复发,并在手术后1年死于与疾病相关的并发症。结论:产acth的pNEN是一种非常罕见的疾病,预后较差。指导治疗决策的有力证据有限。本报告表明,对原发性和转移性病变进行积极的手术治疗是合理的,与先前的病例报告一致。控制内分泌异常提供了延长生存的最佳机会,积极的手术方法可以实现这一目标。患者术后内分泌异常得到控制9个月后才出现症状性疾病复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信